We herein propose an integrated mechanism in cancer by which glycans alterations regulate the intricated signaling pathways mediated by the insulin/IGF system with impacts on cancer cell behaviour, cancer cell metabolism, cancer drug resistance and cancer stemness. This evidence concerns the gene INS and cancer.